Takayama K - Search Results

1

Molecular basis for treating endometriosis with aromatase inhibitors.

Bulun SE, Zeitoun KM, Takayama K, Sasano H. Bulun SE, et al. Among authors: takayama k. Hum Reprod Update. 2000 Sep-Oct;6(5):413-8. doi: 10.1093/humupd/6.5.413. Hum Reprod Update. 2000. PMID: 11045871

2

Treatment of severe postmenopausal endometriosis with an aromatase inhibitor.

Takayama K, Zeitoun K, Gunby RT, Sasano H, Carr BR, Bulun SE. Takayama K, et al. Fertil Steril. 1998 Apr;69(4):709-13. doi: 10.1016/s0015-0282(98)00022-3. Fertil Steril. 1998. PMID: 9548162 Free article.

3

Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element.

Zeitoun K, Takayama K, Michael MD, Bulun SE. Zeitoun K, et al. Among authors: takayama k. Mol Endocrinol. 1999 Feb;13(2):239-53. doi: 10.1210/mend.13.2.0229. Mol Endocrinol. 1999. PMID: 9973254

4

Aromatase as a therapeutic target in endometriosis.

Bulun SE, Zeitoun KM, Takayama K, Simpson E, Sasano H. Bulun SE, et al. Among authors: takayama k. Trends Endocrinol Metab. 2000 Jan-Feb;11(1):22-7. doi: 10.1016/s1043-2760(99)00216-7. Trends Endocrinol Metab. 2000. PMID: 10652502 Review.

5

Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.

Bulun SE, Zeitoun K, Takayama K, Noble L, Michael D, Simpson E, Johns A, Putman M, Sasano H. Bulun SE, et al. Among authors: takayama k. Endocr Relat Cancer. 1999 Jun;6(2):293-301. doi: 10.1677/erc.0.0060293. Endocr Relat Cancer. 1999. PMID: 10731122 Review.

6

Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance.

Bulun SE, Zeitoun KM, Takayama K, Sasano H. Bulun SE, et al. Among authors: takayama k. J Mol Endocrinol. 2000 Aug;25(1):35-42. doi: 10.1677/jme.0.0250035. J Mol Endocrinol. 2000. PMID: 10915216 Review.

7

Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome.

Takayama K, Fukaya T, Sasano H, Funayama Y, Suzuki T, Takaya R, Wada Y, Yajima A. Takayama K, et al. Hum Reprod. 1996 Jul;11(7):1387-92. doi: 10.1093/oxfordjournals.humrep.a019405. Hum Reprod. 1996. PMID: 8671472

8

Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.

Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B, Bulun SE. Zeitoun K, et al. Among authors: takayama k. J Clin Endocrinol Metab. 1998 Dec;83(12):4474-80. doi: 10.1210/jcem.83.12.5301. J Clin Endocrinol Metab. 1998. PMID: 9851796

9

[Endometriosis and aromatase inhibitor].

Takayama K, Bulun SE. Takayama K, et al. Nihon Rinsho. 2001 Jan;59 Suppl 1:157-60. Nihon Rinsho. 2001. PMID: 11235156 Review. Japanese. No abstract available.

10

Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.

Noble LS, Takayama K, Zeitoun KM, Putman JM, Johns DA, Hinshelwood MM, Agarwal VR, Zhao Y, Carr BR, Bulun SE. Noble LS, et al. Among authors: takayama k. J Clin Endocrinol Metab. 1997 Feb;82(2):600-6. doi: 10.1210/jcem.82.2.3783. J Clin Endocrinol Metab. 1997. PMID: 9024261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,233 results

Search Page

Filters